Buscar recursos académicos

Aim. To determine the clinical features of moderate community-acquired pneumonia (CAP) associated with COVID-19 in patients without comorbidities compared to those with comorbid metabolic dysfunction-associated steatotic...

Abstract Background Individuals with abnormal glucose metabolism are at high risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD). Severe hepatic steatosis represents a critical transition ...

ABSTRACT Background Low muscle mass is increasingly recognized to extend beyond aging and is closely linked to metabolic dysfunction. Its population‐level burden, ethnic disparities, metabolic clustering and mortality ...

The peroxisome proliferator-activated receptors (PPARs), including PPAR-α, PPAR-β/δ, and PPAR-γ, are nuclear receptors that play critical roles in regulating metabolism and inflammation. While PPARs have been extensi...

Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of morbidity and mortality due to chronic liver disease. There is an extensive body of evidence focusing on pharmacotherapy...

ObjectiveMetabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent condition with limited established dietary therapies. Lifestyle modifications, particularly dietary adjustments, represent the prim...

Vascular and metabolic diseases, including atherosclerosis, aortic aneurysm and dissection, obesity, type 2 diabetes, and metabolic dysfunction–associated steatotic liver disease (MASLD), constitute a major global heal...

Materias / palabras clave: masld, alcoholic liver disease, liver cancer, drug-induced liver injury, genetic liver disease, cirrhosis; Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology